Rhabdomyolysis



Ovid: 5-Minute Sports Medicine Consult, The


Rhabdomyolysis
Cherise Russo
Basics
Description
  • Syndrome associated with muscle injury and systemic release of intracellular contents, such as creatine phosphokinase (CPK)
  • A combination of myoglobinuria, hypovolemia, and aciduria leads to acute renal failure.
  • Direct release of potassium from damaged muscle tissue may lead to dysrhythmias and sudden death.
Epidemiology
  • Occurs in up to 85% of trauma patients
  • 10–50% of patients with rhabdomyolysis will develop acute renal failure.
  • ∼26,000 people are affected in the U.S. each year.
  • Exact incidence of exertional rhabdomyolysis is unknown, but is likely comparable to military reports of 0.3–3%
Risk Factors
  • Heritable muscle enzyme deficiencies
  • Electrolyte abnormalities
  • Infections
  • Drugs
  • Toxins
  • Endocrinopathies
  • Exercise in high heat
  • Exercise in high humidity
  • Sudden increase in physically demanding exercise
  • Exercise in dehydrated state
Genetics
Metabolic myopathies:
  • Small percentage of total cases
  • Inherited disorders:
    • Disorder of glycogenolysis
    • Disorder of glycolysis
    • Disorder of lipid metabolism
    • Disorder of purine metabolism
    • Mitochondrial myopathies
  • Increased suspicion when patients have recurrent episodes of rhabdomyolysis associated with exercise
Etiology
Muscle damage and/or necrosis that results in elevation in CPK levels, electrolyte disturbances, and renal compromise:
  • Trauma/crush injuries (motor vehicle accidents, fall from seizure or stroke, struggle against restraints, abuse, prolonged tourniquet)
  • Exercise
  • Hyperthermia (heat stroke, malignant hyperthermia, and neuroleptic malignant syndrome)
  • Hypothermia
  • Prolonged immobile state
  • Drugs/toxins (alcohols, cocaine, amphetamines, opiates, antihistamines, barbiturates, phencyclidine, caffeine, carbon monoxide, cholesterol-lowering agents, succinylcholine, snake venom, bee/hornet venom, etc.)
  • Chronic electrolyte disturbances (hypokalemia, hypophosphatemia, hypoxia)
  • Infections (viral, bacterial, parasitic, protozoan, rickettsial)
  • Endocrinopathies (hyperthyroid state, diabetic ketoacidosis, hyperosmolar)
  • Burn or electrical injury
  • Genetic disorders/metabolic myopathies (McArdle's disease, Tarui's disease)
  • Hematologic disorder (sickle cell trait)
  • Immunological disorders (dermatomyositis, polymyositis)
  • Idiopathic
Diagnosis
  • General symptoms include: Malaise, fever, tachycardia, nausea/emesis along with myalgia
  • Typically, the patient demonstrates decreased flexibility and decreased strength secondary to pain.
  • Muscle pain, reduced flexibility, decreased/painful strength
  • History and physical are insensitive in making the diagnosis.
  • Serum CPK level is criterion standard and must be sent if any clinical suspicion exists.
  • Serum electrolytes, BUN, creatinine, calcium, and liver enzyme levels should be obtained.
    • Urine dipstick that is positive for heme but absent for RBCs suggests rhabdomyolysis (myoglobinuria):
      • Because of rapid urinary excretion of myoglobin, up to 26% of patients with rhabdomyolysis have negative urine dipstick.
History
  • Wide range of severity of symptoms
  • Classic features: Myalgia, weakness, and dark urine (seen in <10% of patients)
  • General symptoms include: Malaise, fever, tachycardia, nausea/emesis
Physical Exam
  • Signs and symptoms can vary dramatically, reflecting underlying disease process.
  • Obvious crushing injury
  • Hypothermia/hyperthermia
  • Patient may be either alert or obtunded
  • Muscle tenderness, swelling (calves and lower back most commonly involved)
  • Change in urine color; orange to cola-colored to black
  • Hypovolemic state, dry mucous membrane, poor skin turgor, tachycardia, hypotension
  • Decreased urine output
Diagnostic Tests & Interpretation
Lab
  • CPK levels are the most sensitive; CK-MM isoenzyme is most elevated
  • CPK levels rise within 12 hr, peak in 1–3 days, and reduce 3–5 days after underlying cause of muscle injury is addressed.
  • CPK levels >5,000 U/L relate to renal failure.
  • Serum and urine myoglobin levels useful in acute phase; has short half-life and may return to normal within 6–8 hr
  • Perform urine dipstick to evaluate for myoglobinuria and urine analysis to detect casts, protein, and uric acid crystals.
  • Arterial blood gas
  • Carbonic anhydrase III more specific for skeletal muscle
  • Metabolic profile (hyperkalemia, hypocalcemia, hyperphosphatemia, hyperuricemia)
  • Blood urea nitrogen level to creatinine ratio decreases to 6:1 or less
  • Serum glucose, lactate dehydrogenase, serum glutamic oxaloacetic transaminase, albumin
  • Toxicology screen in absence of physical injury
  • Prothrombin time/partial thromboplastin time, platelet count, fibrinogen, fibrin-split products if disseminated intravascular coagulopathy is suspected
Imaging
  • MRI is 90–95% sensitive in visualizing muscle injury.
  • MRI is not typically ordered because the imaged muscle damage does not change initial treatment.
Diagnostic Procedures/Surgery
Forearm ischemic test:
  • To differentiate genetic causes of rhabdomyolysis
  • Performed after rhabdomyolysis is resolved
  • Obtain baseline ammonia and lactic acid levels.
  • Inflate sphygmomanometer to >200 mm Hg.
  • Patient performs hand-grip exercises to fatigue.
  • Cuff is removed and serial blood tests are drawn.
  • Minimal or no rise in lactic acid suggests carbohydrate metabolism disorder or McArdle's disease.
  • Delayed rise or no rise in the ammonia level suggests myoadenylate deaminase deficiency.
  • Normal rise in ammonia and lactic acid levels suggests the presence of a disorder of lipid metabolism.
Differential Diagnosis
The following conditions may present with elevated serum CPK but may not lead to complications of rhabdomyolysis:
  • Nontraumatic myopathies
  • Renal failure
  • IM injections
  • Myocardial injury
  • Hypothyroidism
  • Hyperthyroidism
  • Stroke
  • Surgery

P.513


Ongoing Care
  • Underlying cause of rhabdomyolysis should be determined if etiology was not discovered during hospital stay.
  • Genetic testing and muscle biopsies should be considered when warranted.
  • Medications, if implicated, should be stopped.
  • Metabolic-modifying supplements and enhancing agents should be stopped.
  • Activity modification if exercise-induced
Follow-Up Recommendations
  • No specific guidelines exist for return to exercise after exertional rhabdomyolysis.
  • Areas to consider:
    • Symptoms should be completely resolved.
    • All bloodwork and urine tests should be within normal limits.
    • Examination should demonstrate clinical resolution.
    • Patient should be able to demonstrate full strength.
    • Gradual return to exercise with acclimatization and adequate hydration
    • Return to exercise should begin with mild to moderate intensity.
Patient Monitoring
  • Initially, patient should be monitored clinically at regular short intervals.
  • For example, the physician may want to re-evaluate the athlete every 48 hr as intensity increases.
Diet
  • Education should be provided about hydration.
  • Specific diet recommendations may be considered for specific myopathies.
Patient Education
Prevention strategies for return to sports after rhabdomyolysis:
  • Appropriate hydration counseling should be provided.
  • Gradual return to exercise may include acclimatization.
  • Return to exercise should begin with mild to moderate intensity.
  • Advise against significant dietary changes initially.
  • Athlete should be advised to stop activity if he or she experiences similar symptoms and physician should be contacted immediately.
Codes
ICD9
728.88 Rhabdomyolysis


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More